Supplementary Fig. S1. An example of the fluorescence of the negative control dog serum tested by IFAT at a dilution of 1:40.
Supplementary Fig. S2. An example of the fluorescence of the positive control dog serum tested by IFAT at a dilution of 1:80.
Supplementary Methods S1.
Supplementary Methods S2.
Supplementary Methods S3.
Supplementary Table S1. Definitions for infection, disease and chronic carrier (extracted from Rothman et al., 2008, p551 Table 27.1)
Supplementary Table S2. Laboratory and clinical findings for the negative and positive control dogs for the Indirect Fluorescent Antibody Tests (IFATs)
Supplementary Table S3. Laboratory, demographic and clinical data for the 37 dogs confirmed positive for exposure to Babesia rossi by Indirect Fluorescent Antibody Test (IFAT, at 1:80 dilution) in February and March 2010
Supplementary Table S4. Laboratory, demographic and clinical data for the 18 dogs positive for Babesia spp. on blood smear examination in July 2009, February 2010, August 2010 and/or February 2011